Efficient biosynthesis of the plant polyphenol pinosylvin, which has numerous applications in nutraceuticals and pharmaceuticals, is necessary to make biological production economically viable. To this end, an efficient Escherichia coli platform for pinosylvin production was developed via a rational modular design approach. Initially, different candidate pathway enzymes were screened to construct de novo pinosylvin pathway directly from D-glucose. A comparative analysis of pathway intermediate pools identified that this initial construct led to the intermediate cinnamic acid accumulation. The pinosylvin synthetic pathway was then divided into two new modules separated at cinnamic acid. Combinatorial optimization of transcriptional and translational levels of these two modules resulted in a 16-fold increase in pinosylvin titer. To further improve the concentration of the limiting precursor malonyl-CoA, the malonyl-CoA synthesis module based on clustered regularly interspaced short palindromic repeats interference was assembled and optimized with other two modules. The final pinosylvin titer was improved to 281 mg/L, which was the highest pinosylvin titer even directly from D-glucose without any additional precursor supplementation. The rational modular design approach described here could bolster our capabilities in synthetic biology for value-added chemical production.
The polyphenol pinosylvin (trans-3,5-dihydroxystilbene) is a plant secondary metabolite fulfilling several functions including protection from attack by microbes or insects 1 . Pinosylvin has emerged as a promising nutraceutical or pharmaceutical because of its antioxidative, anti-inflammatory, anticancer, and chemopreventive activities 2 . Pinosylvin is primarily existed in the heartwood of genus Pinus. However, the concentration of this compound in plants only ranges from 1 to 40 mg/g 3 , rendering access to this medicinally important product through plant extraction difficult. Additionally, isolation of single compound from plants is limited by seasonal and regional variations and often difficult due to the complexity of secondary metabolites from plant extracts 4 . Alternatively, microbial production of pinosylvin may accelerate its large-scale production and is more environmentally friendly 5 . The conversion of the aromatic amino acid L-phenylalanine to pinosylvin requires three steps (Fig. 1) . Firstly, phenylalanine ammonia lyase (PAL) deaminates L-phenylalanine to cinnamic acid. 4-Coumarate:CoA ligase (4CL) subsequently converts cinnamic acid into its corresponding coenzyme A ester cinnamoyl-CoA. The resulting cinnamoyl-CoA is then condensed with three units of malonyl-CoA via stilbene synthase (STS) to form the stilbene pinosylvin 4 . To date, several studies have made significant achievements for microbial production of stilbene 4, 5 , particularly for synthesizing resveratrol 6, 7 . For example, relevant study reported that supplementation of 15 mM p-coumaric acid led to a high product titer of 2.3 g/L resveratrol in Escherichia coli 6 . However, these strategies rely heavily on supplementation of phenylpropanoids as stilbene precursors, which is costly and present in few industrial processes.
In contrast, de novo microbial pinosylvin production makes biological production economically viable and would accelerate the application of pinosylvin as both nutraceutical and pharmaceutical. Previous studies have demonstrated the feasibility of microbial production of pinosylvin from D-glucose or glycerol. In one relevant study, researchers constructed different configurations of three-step pinosylvin biosynthetic pathway and up to 3 mg/L titer was achieved. Further addition of fatty acid synthesis inhibitor cerulenin increased product titer to 70 mg/L 4 . As cerulenin is expensive and cost prohibitive for large-scale fermentation process, another study examined using clustered regularly interspaced short palindromic repeats interference (CRISPRi) system to repress fadD gene, and product titer of 47.5 mg/L was obtained from glycerol 5 . Additionally, Corynebacterium glutamicum also has been engineered and 121 mg/L of pinosylvin and 158 mg/L of resveratrol was achieved in the presence of 25 μM cerulenin 8 . Despite exciting achievements under these methods, there is a pressing need to develop more economically viable process with high productivity and yield. However, the most difficult part exists in finding and applying effective resolutions to overcome metabolic flux imbalances when implementing a heterologous pathway using non-natural substrates 9, 10 . De novo pinosylvin synthesis from D-glucose involves manipulating multi-gene pathways that are subjected to tight cellular regulation. Previous studies always engineered part of the overall pathway such as L-phenylalanine to pinosylvin or even from cinnamic acid 4, 5 , ignoring the balance of the overall pathway. It was hypothesized that one pathway bottleneck might be eliminated while another bottleneck might be brought in somewhere else along the pathway when examining only part of the pinosylvin pathway 11 . Furthermore, endogenous central metabolism still strongly competes and predominates for energy and carbon sources during the synthesis of malonyl-CoA synthesis, leaving only a few amounts for producing recombinant products 12, 13 . More recently, we introduced a modular metabolic engineering strategy to balance resveratrol synthetic pathway and achieved 35 mg/L resveratrol from 3 mM L-tyrosine 14 . Despite the potential of modular metabolic engineering to significantly bolster the capabilities in synthetic biology 15 , this area still lacks a standard principle for module grouping and further optimization. Here, a rational modular design approach was developed for grouping and optimizing modules. Compared to our previous studies 14, 16, 17 , this rational modular design approach demonstrated that choosing separating node at cinnamic acid rather than previous cinnamoyl-CoA lead to a dramatic increase in final production titer. Final pinosylvin titers were improved to 281 mg/L, which represented the highest titer reported to date. This rational modular design approach provides a framework for module grouping and optimization and would expedite developing robust and efficient microbial cell factories for value-added chemical production. 
Results
Design of de novo pinosylvin synthetic pathway. For de novo microbial production of pinosylvin, strains displaying enhancing ability for the synthesis of L-phenylalanine are required. In E. coli, two rate-limiting steps exist toward the synthesis of L-phenylalanine. The first one is the condensing erythrose 4-phosphate (E4P) and phosphoenolpyruvate (PEP) via 3-deoxy-D-arabinoheptulosonate 7-phosphate synthase (DAHP) synthase isozymes encoded by aroG, aroF and aroH. The second one is the conversion of chorismate (CHO) to phenylpyruvate (PPY) via chorismate mutase/prephenate dehydratase (CM/PDT). Previously, a β-2-thienylalanine-resistant E. coli K12 mutant exhibiting high titers of L-phenylalanine was obtained 18 . This strain carried a wild-type DAHP synthase (DAHPS: aroF wt ) and a mutant CM/PDT (CM/PDT: pheA fbr ). As such, aroF wt and pheA fbr were overexpressed to enhance L-phenylalanine synthesis 19 .
As the first step of phenylpropanoid pathway, two candidate PAL enzymes were chosen. One was selected from the red yeast Rhodotorula glutinis (RgPAL), which was successfully used in our previous studies 16, 19 . The other one was chosen from Trichosporon cutaneum (TcPAL), which was a novel phenylalanine/tyrosine ammonia-lyases exhibiting high activities toward both L-phenylalanine and L-tyrosine 20 . 4CL from Petroselinum crispum and STS from Vitis vinifera served as the second and third enzyme because these two enzymes achieved the highest production of stilbene resveratrol in E. coli demonstrated by previous study 6 .
Analysis of pathway intermediate pools.
Based on our previous study, aroF wt and pheA fbr under T7 promoter in pCOLADuet-1 (pCOLA-aroF wt -pheA fbr ), RgPAL or TcPAL and 4CL under Trc promoter in pCDFDuet-1 (pCDFD-Trc-RgPAL-Trc-4CL or pCDFD-Trc-TcPAL-Trc-4CL), STS under T7 promoter in pETDuet-1 (pETD-STS) were overexpressed in E. coli BL21(DE3) strain to construct the initial fermentation platform, as this combination always led to the highest flavonoid 16, 21 or stilbene titer 14 . We found that the combination containing TcPAL produced higher pinosylvin (10.5 mg/L) than RgPAL (3.7 mg/L). To confirm the TcPAL activity, the RgPAL and TcPAL were cloned into pCDFDuet-1 individually and it was found that E. coli with TcPAL produced higher cinnamic acid (466 mg/L) than RgPAL (249 mg/L) ( Table 1) . Hence, TcPAL was used for the following research.
Furthermore, by a comparative analysis of pathway intermediate concentrations (Table 1) , we found that these two combinations (pCOLA-aroF wt -pheA fbr , pCDFD-Trc-RgPAL-Trc-4CL or pCDFD-Trc-TcPAL-Trc-4CL, pETD-STS) both led to high accumulation of cinnamic acid. Therefore, results from this metabolite analysis indicated that efficient conversion of cinnamic acid presented the pathway bottleneck, suggesting that subsequent engineering efforts should focus on addressing this obstacle.
Rational modular design of the overall pathway to remove the pathway bottleneck. To improve the efficiency of this functional pathway, the overall pathway was re-designed as two new modules separated at cinnamic acid rather than previous three modules. Module one comprised a three-gene, upstream pathway to cinnamic acid, which consisted of aroF wt , pheA fbr and TcPAL. Module two comprised a two-gene, downstream pathway to pinosylvin, which consisted of 4CL and STS (Fig. 1) . Five different plasmids of pCOLADuet-1 (COLA origin), pACYCDuet-1 (p15A origin), pCDFDuet-1 (CDF origin), pETDuet-1 (pBR322 origin) and pRSFDuet-1 (RSF origin) and two promoters of T7 and Trc were used to regulate modular expression. The gene copy numbers of pCOLADuet-1, pACYCDuet-1, pCDFDuet-1, pETDuet-1, and pRSFDuet-1 were assigned as 5, 10, 20, 40 and 100, respectively according to previous reports 15, 19 . The promoter strengths were designated as T7 = 5, Trc = 1 15 . At the very start, module two was overexpressed relative to module one to alleviate cinnamic acid accumulation (Fig. 2) . In the first round (S1-S8), module one was expressed at a lowest value (COLA × Trc, 5 a.u.), while module two expression increased from a higher value (p15A × Trc, 10 a.u.). It was found that the pinosylvin titer increased from 0.6 mg/L to 3.2 mg/L until an intermediate value (p15A × T7, 50 a.u.) and the titer of intermediate product cinnamic acid decreased from 431 mg/L to 386 mg/L following an opposite trend. This result suggested that the low expression of module one were not suitable for the high expression of module two. Additionally, it was found that use of pRSFDuet-1 in every combination (S5 and S8) led to low titers of pinosylvin and high titers of intermediate cinnamic acid. Furthermore, the final OD600 of these two strains were 2.6 and 2.2, respectively. Hence, it was supposed that the high copy number of pRSFDuet-1 would increase metabolic burden and further lead to negative effect on cell behavior. (pCDF × T7), respectively, while module two expression increased from a higher value compared to module one. It was observed that when module one expression elevated to 50 a.u. (p15A × T7), the titer of pinosylvin increased following the increasing expression of module two and highest pinosylvin production (61 mg/L) was obtained with the highest expression of module two (200 a.u., pBR322 × T7).
In this study, the relative heterologous gene expression strength is calculated based on promoter strength and the plasmid gene copy number. To support this calculation, transcriptional expression levels of TcPAL, 4CL and STS were calculated by qPCR from strains of S1, S9, S13, S17 and S20, as these strains exhibited different gene expression levels. As seen from Fig. 3A , the mRNA transcriptional level directly sustained this calculation method that increasing plasmid gene copy number and promoter strength modulated heterologous gene expression.
To further support this conclusion, the plasmids of pCDFD-T7-TcPAL, pCDFD-Trc-TcPAL, pACYC-T7-TcPAL and pETD-T7-TcPAL were transformed into BL21 (DE3) strain to compare the in vivo TcPAL activity under different plasmids and promoters. These engineered strains were supplemented with 1 g/L L-phenylalanine. It was found that pETD-T7-TcPAL (200 a.u.), pCDFD-T7-TcPAL (100 a.u.), pACYC-T7-TcPAL (50 a.u.) and pCDFD-Trc-TcPAL (20 a.u.) obtained 689 mg/L, 478 mg/L, 205 mg/L and 120 mg/L cinnamic acid, respectively (Fig. 3B ). This further demonstrated the feasibility of the method described above. PAL   T7   STS  4CL  CDF   T7   T7   pheA  aroF  p15A   T7  T7   PAL   T7   STS  4CL  CDF   T7   T7   pheA  aroF  p15A   T7  T7   PAL   T7   STS  4CL  pBR322   T7   T7   pheA  aroF  pCDF   T7  T7   PAL   T7   STS  4CL  pBR322 T7 S19 S20 S19 S20 S17 S18 S9 S10 S11 S12 S13 S16 S14 S15 S9 S10 S11 S12 S13 S14 S15 S16 S17 Optimization of module two by changing 5′ region of mRNA secondary structure. As seen from Fig. 2 , in the final round of modular engineering, the titer of pinosylvin increased following the increasing expression of module two and highest pinosylvin production was obtained with the highest expression of module two. That means increasing module two expression would be favorable for pinosylvin production. However, employment of high copy number plasmid pRSFDuet-1 led to high metabolic burden and resulted in negative effect on cell behavior. This genetic recalcitrance restricted the ability to balance the overall pathway. Previously, we demonstrated that reducing the 5′ region secondary structure of the open reading frame of target gene mRNA could function in improving protein expression with no additional metabolic burden 16 . Hence, in this study, this strategy was further developed to optimizing and balancing the heterologous gene expression coding for enzymes of the pinosylvin production pathway.
Firstly, the expression of 4CL was optimized via reducing its 5′ region secondary structure of the open reading frame of mRNA. Based on our previous study 16 , changing synonymous codon usage in the first 14 amino acids of N-terminal protein was performed. For each codon, the first and second positions were kept constant while the third base position mutated randomly. On the basis of translation start site (ATG) to 42 base sequence (+1 to +42), the minimum free energy of folding for the 5′ region of mRNA transcript (ΔG) was calculated by NUPACK software 22 (Fig. 4) . As seen in Fig. 5 , a total of seven variants spanning a range of free energies from −12.8 to −4.1 kcal/mol were chosen. These different variants of 4CL were used to replace the original 4CL in module two to further balance the overall pathway. ΔG of original 4CL was −12.8 kcal/mol. It was found that variants with reduced 5′ region of mRNA secondary structure (larger value of ΔG) increased the pinosylvin production (97 mg/L) until ΔG value of −5.0 kcal/mol. While the concentration of the intermediate product cinnamic acid continuously decreased from 168 to 114 mg/L.
It was observed that continuously reducing the 4CL mRNA secondary structure decreased cinnamic acid accumulation constantly while the pinosylvin production increased until an intermediated value of ΔG. This result meant STS may present as another pathway bottleneck. Hence, six different STS variants spanning a range of free energies from −9.4 to −4.4 kcal/mol were also chosen to replace the original STS (Fig. 6) . It was found that variants with reduced 5′ region of mRNA secondary structure increased pinosylvin production from 96 mg/L to 160 mg/L (Fig. 7) . It was notably that modifying the expression of STS resulted in a dramatic change of pinosylvin production and the low activity of STS would be another pathway bottleneck.
Construction of CRISPRi system to enhance malonyl-CoA concentration. To further improve the intracellular availability of the limiting precursor malonyl-CoA, the malonyl-CoA synthesis module (module three) based on CRISPRi was assembled and optimized with other two modules. Based on our previous studies 12, 17 , low repressing efficacy toward genes of eno, adhE fabB (anti-eno, anti-adhE, anti-fabB sgRNA), medium repressing efficacy toward genes of sucC and fumC (anti-sucC, anti-fumC sgRNA) and high repressing efficacy toward genes of fabF (anti-fabF sgRNA) were conducted in engineered BL21(DE3) strains, because repression of these genes would not alter final biomass significantly while enhancing the intracellular malonyl-CoA level.
In order to verify the repressing efficiency of CRISPRi system, the malonyl-CoA concentration and the changing pattern of target gene mRNA levels from each engineered strain were measured. The target gene mRNA levels from CRISPRi-regulated strains were calculated compared to the control. It was found that the transcriptional levels of eno, adhE, fabB, sucC, fumC, fabF mRNA from CRISPRi-regulated strains decreased by 38.1%, 47.3%, 39.6%, 69.2%, 78.2%, 91.7%, respectively. Silencing of eno, adhE, fabB, sucC, fumC, fabF increased the intracellular malonyl-CoA concentration by 98.4%, 255.9%, 144.4%, 177.8%, 200.7%, 288.9%, respectively (Fig. 8A) .
Furthermore, the effect of multiple genetic disturbance on pinosylvin production were explored (Fig. 8B ). Different sgRNA sequences involving Trc promoter, complementary region, dCas9-binding hairpin and transcription terminator were inserted into the same plasmid to repress multiple genes. Repressing adhE, eno, fabB, fabF, fumC and sucC increased pinosylvin titer by up to 8.8%, 13.8%, 18.8%, 23.1%, 11.9% and 14.3%, respectively. Then repressing fabF with stacking of other genetic interventions were investigated, as the highest pinosylvin titer was obtained when fabF was repressed (197 mg/L). It was found that anti-fabF/fabB sgRNA led to the highest pinosylvin titer (221 mg/L). Similarly, silencing of fabF and fabB with adhE, eno, fumC and sucC were investigated and anti-fabF/fabB/eno sgRNA produced the highest titer (241 mg/L). Furthermore, we found that anti-fabF/fabB/eno sgRNA associated with anti-sucC, anti-adhE or anti-fumC sgRNA led to higher pinosylvin titer than anti-fabF/fabB/eno sgRNA, and anti-fabF/fabB/eno/adhE sgRNA resulted in the highest pinosylvin titer (257 mg/L). Anti-fabF/fabB/eno/adhE sgRNA associated with anti-sucC, or anti-fumC sgRNA also led to higher production titer, and anti-fabF/fabB/eno/adhE/fumC sgRNA exhibited the highest titer (272 mg/L). Finally, we demonstrated that anti-fabF/fabB/eno/adhE/fumC/sucC sgRNA exhibited the highest pinosylvin titer (281 mg/L).
Discussion
Efficient biosynthesis of pinosylvin from renewable and cheap substrate D-glucose would accelerate the application of pinosylvin as both nutraceutical and pharmaceutical. Previous studies on pinosylvin production have C o n tr o l a n ti -e n o a n ti -a d h E a n ti -f a b B a n ti -s u c C a n ti -f u m C a n ti -f a b F A B C o n tr o l a n ti -a d h E a n ti -e n o a n ti -f a b B a n ti -f a b F a n ti -f u m C a n ti -s u c C a n ti -f a b F /a d h E a n ti -f a b F /e n o a n ti - mainly focused on engineering the three-step pathway ranging from L-phenylalanine to pinosylvin 4, 5 . Despite these significant achievements, further improvement in pinosylvin production need investigating metabolic constraints and removing pathway limitations throughout the overall pathway instead of only partial pathway. In this study, by a rational modular design approach, the overall pinosylvin biosynthetic pathway including a total of 11 genes was constructed and arranged into three modules (Fig. 1) . These modules were systematically optimized for efficient microbial production and the final engineered strain could produce 281 mg/L pinosylvin. The present work demonstrated that this rational modular design approach would expedite developing robust and efficient microbial cell factory for value-added chemical production.
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The ability to more broadly use biological systems for chemical production is always limited by the inefficiency of complex biosynthetic pathways in heterologous hosts 11, 23, 24 . Despite the potential of modular metabolic engineering to revolutionize the field of synthetic biology 15 , the field of synthetic biology still lacks a standard principle for strain optimization. The rational modular design approach described here provides a framework for fine-tuning synthetic pathways, identifying potential pathway bottlenecks and further alleviating them. Initially, different candidate pathway enzymes were screened to construct the overall pathway. Secondly, metabolite profiling indicated that cinnamic acid accumulated in the initial strain (Table 1) , the pinosylvin synthetic pathway was then divided at a new node cinnamic acid. These new modules were combinatorially optimized at transcriptional and translational levels, which exhibited a 16-fold increase in pinosylvin titer compared to the initial construct (Fig. 2) . It is notably that choosing separating node at cinnamic acid rather than previous cinnamoyl-CoA 16, 17 lead to a dramatic increase in final production titer. This further highlighted the importance of selecting suitable separating node in modular pathway engineering. The present work reports a rational modular design approach for systematically identifying and removing metabolic bottlenecks.
Compared to the initial modular pathway engineering strategies only employing different plasmids and promoters to fine-tuning pathway efficiency 15, 19, 21 , in this work, we further explored reducing 5′ mRNA secondary structure and synthetic CRISPRi system to modulate pinosylvin biosynthetic pathway and endogenous central metabolism. Based on these combined strategies, our analyses revealed that accumulation of cinnamic acid, low stilbene synthase activity and limited malonyl-CoA availability were the main bottlenecks of the overall pathway and led to engineering efforts that significantly increased pinosylvin titer to 281 mg/L, which represents the highest titer reported to date in microbial production strains. This demonstrated that emerging synthetic devices and strategies in the context of synthetic biology would greatly complement modular pathway engineering to exploit the full potential of cell metabolism 23, [25] [26] [27] . Natural genes often exhibit a bias preference of codon usage and could strongly influence the expression of heterologous genes 28 . In order to improve the expression of heterologous genes, researchers always replace non-optimal codons by optimal ones. However, previous studies find that many organisms are enriched for rare codons at 5′ region of genes and local RNA structure in 5′ region of genes mostly influence expression change 28, 29 . Furthermore, we proved that weakening 5′ region of target gene mRNA secondary structure enhanced gene expression levels dramatically 16 . Here, it was found that increasing module two expression would be favorable for pinosylvin production. However, employment of high copy number plasmid pRSFDuet-1 resulted in negative effect on cell behavior due to the large metabolic burden. Hence, in this study, the strategy was further developed to optimizing module two expression instead of employment of high copy number plasmid. The balance of the overall pathway was finally achieved and the production titer of pinosylvin increased by 1.6-fold (160 vs 62 mg/L). Besides, this strategy described here identified that the low activity of STS was one of the pathway bottlenecks, suggesting a strategy for identifying pathway bottlenecks.
Endogenous central metabolism strongly competes and predominates for energy and carbon sources when synthesizing malonyl-CoA 12, 13 , leaving only a few amounts for pinosylvin production. In one relevant study, researchers demonstrated that addition of fatty acid synthesis inhibitor cerulenin increased production titer significantly 4 . While cerulenin is costly prohibitive for large-scale fermentation process, another study explored using CRISPRi system to repress fadD gene and obtained a 1.9-fold increase on production titer 5 . However, it is urgently needed to examine other metabolic engineering targets and further evaluate combinatorial effect of different genetic interventions.
Here, it was found that repression of eno, adhE, fabB, sucC, fumC and fabF could improve the intracellular malonyl-CoA concentration. It was presumed that repression of eno would channel carbon flows toward pyruvate (acetyl-CoA precursor), repression of adhE, sucC and fumC would decrease the consumption of acetyl-CoA in TCA cycle or glycolysis and repression of fabB and fabF would prevent the diversion of malonyl-CoA to the synthesis of fatty acid 12 . Furthermore, the combinatorial effect of various genetic interventions implicated in central metabolic pathways was explored and the best combination was obtained (Fig. 8) . Our study demonstrated that CRISPRi system coupled with modular pathway engineering strategy are powerful tools with which to expand methods and strategies for systematic engineering of industrially important microorganisms.
Materials and Methods
General techniques. Luria broth (LB) and E. coli JM109 were employed for plasmid construction, MOPS minimal medium 30 with additional 5 g/L glucose and 4 g/L NH 4 Cl and E. coli BL21 (DE3) were employed to express heterologous genes. Ampicillin (100 μg/mL), kanamycin (40 μg/mL), chloramphenicol (20 μg/mL), and streptomycin (40 μg/mL) were supplemented to maintain the existing of the compatible vectors pETDuet-1, pRSFDuet-1, pACYCDuet-1, pCDFDuet-1, pRSFDuet-1, and pACYCDuet-1 (Novagen, Darmstadt, Germany). Pinosylvin was purchased from Sigma-Aldrich (P56297). DNA ligase and restriction enzymes were purchased from Novagen (Darmstadt, Germany). PAL from Rhodotorula glutinis (RgPAL) 31 , PAL from Trichosporon cutaneum (TcPAL) 20 , 4CL from Petroselinum crispum, STS from Vitis vinifera 6 were codon-optimized for E. coli expression (http://www.jcat.de/), synthesized by GenScript (Nanjing, China). The sequences of all synthesized Scientific RepoRts | 7: 1459 | DOI:10.1038/s41598-017-01700-9 genes are showed in the Supplementary Material. A UV/vis spectrophotometer (UVmini-1240, Shimadzu, Kyoto, Japan) was used to measure absorbance at 600 nm (OD 600 ).
Synthetic pathway construction.
Colony PCR and Sanger sequencing were employed to confirm all constructed plasmids. Primers and plasmids present in this study are showed in Tables 2 and 3, respectively. Primers Pf_Trc (PfoI) and Pr_Trc (FseI) were employed to clone the Trc promoter, multi-cloning sites and corresponding terminator from pTrcHis2B to the sites of PfoI/FseI in pCDFDuet-1, pRSFDuet-1, respectively. This resulted in pCDFD-Trc, pRSFD-Trc. Primers Pf_Trc (EcoNI) and Pr_Trc (FseI) were used to clone the Trc promoter, multi-cloning sites and rrnB terminator from pTrcHis2B to the sites of EcoNI/FseI in pACYCDuet-1, pETDuet-1, resulted in pACYC-Trc, pETD-Trc. PAL from Trichosporon cutaneum (TcPAL) was independently cloned from pUC57-TcPAL (synthesized by GenScript, Nanjing, China) into pCDFD-Trc using primers Pf_TcPAL (NcoI) and Pr_TcPAL (EcoRI) with enzymes NcoI and EcoRI, which resulted in pCDFD-Trc-TcPAL. 4CL was cloned from pUC57-4CL (synthesized by GenScript, Nanjing, China) into pCDFD-Trc by primers Pf_4CL (NcoI) and Pr_4CL (HindIII) and the enzymes NcoI and HindIII, resulted in pCDFD-Trc-4CL. pCDFD-Trc-TcPAL-Trc-4CL was constructed by amplifying Trc promoter and 4CL (pTrc-4CL region) with primers Pf_Ptrc4CL (EcoRI) and Pr_Ptrc4CL (HindIII) and cloning into pCDFD- . pCDFD-T7-aroF wt -T7-pheA fbr was constructed by amplifying the pT7-pheA fbr region including T7 promoter and pheA fbr from pCDFD-T7-pheA fbr with primers Pf_ Pt7PheA (HindIII) and Pr_Pt7PheA (NdeI) and cloning into pCDFD-T7-aroF wt with HindIII and NdeI. TcPAL was cloned from pUC57-TcPAL into pCDFDuet-1 by primers Pf_TcPAL (NcoI) and Pr_TcPAL (XhoI) and the enzymes NcoI and XhoI, resulted in pCDFD-T7-TcPAL. To construct pCDFD-T7-aroF wt -T7-pheA fbr -T7-TcPAL, the pT7-TcPAL region including T7 promoter and TcPAL was amplified from pCDFD-T7-TcPAL with primers Pf_Pt7TcPAL (NdeI) and Pr_Pt7TcPAL (AvrII) and cloning into pCDFD-T7-aroF wt -T7-pheA fbr with NdeI and AvrII. pACYC-T7-aroF wt -T7-pheA fbr -T7-TcPAL was constructed through the digestion of pCDFD-T7-aroF wt -T7-pheA fbr -T7-TcPAL and pACYCDuet-1 with enzymes EcoNI and AvrII, followed by ligation of the appropriate fragments.
4CL was independently cloned into pCDFD-Trc, pETD-Trc, pRSFD-Trc and pACYC-Trc from pUC57-4CL (GenScript, Nanjing, China) via primers Pf_4CL (NcoI) and Pr_4CL (EcoRI) with the restriction enzymes NcoI and EcoRI, respectively. This resulted in pCDFD-Trc-4CL, pETD-Trc-4CL, pRSFD-Trc-4CL, pACYC-Trc-4CL. STS was independently cloned into pCDFD-Trc from pUC57-STS (GenScript, Nanjing, China) via primers Pf_ STS (NcoI) and Pr_STS (HindIII) with the restriction enzymes NcoI and HindIII, resulted in pCDFD-Trc-STS. The pTrc-STS region including Trc promoter and STS was amplified from pCDFD-Trc-STS with primers Pf_ PtrcSTS (EcoRI) and Pr_PtrcSTS (HindIII) and cloned into pCDFD-Trc-4CL, pETD-Trc-4CL, pACYC-Trc-4CL, pRSFD-Trc-4CL with EcoRI and HindIII to construct pCDFD-Trc-4CL-Trc-STS, pETD-Trc-4CL-Trc-STS, pACYC-Trc-4CL-Trc-STS and pRSFD-Trc-4CL-Trc-STS.
4CL from pUC57-4CL was cloned from pUC57-4CL via primers Pf_4CL (NcoI) and Pr_4CL (HindIII) and the resulting product was inserted into the NcoI/HindIII sites of pETDuet-1, resulted in pETD-T7-4CL. pET-T7-4CL-T7-STS was constructed by amplifying STS from pUC57-STS via primers Pf_STS (NdeI) and Pr_STS (AvrII) and inserting resulting products into the NdeI/AvrII sites of pETD-T7-4CL. pCDFD-T7-4CL-T7-STS, pACYC-T7-4CL-T7-STS and pRSFD-T7-4CL-T7-STS were constructed through the digestion of pETD-T7-4CL-T7-STS and pCDFDuet-1, pACYCDuet-1, pRSFDuet-1 with enzymes NcoI and AvrII, followed by ligating the appropriate fragments. RNA preparation and qPCR. Recombinant cells were collected when cells reached at the stationary phase and subsequently frozen by liquid nitrogen. Total RNA was purified via RNAprep Pure Kit (TIANGEN, Beijing, China). RNeasy Mini Kit ((Takara, Dalian, China) was utilized to remove genomic DNA. NanoDrop ND-1000 Spectrophotometer was utilized to measure RNA quality and quantification (NanoDrop Technologies, Wilmington, DE). The SuperScriptTM III First-Strand Synthesis System (Invitrogen) and total RNA were used to synthesize cDNA 33 . Primers Pf_qPAL/Pr_qPAL, Pf_q4CL/Pr_q4CL, Pf_qSTS/Pr_qSTS, Pf_qeno/Pr_qeno, Pf_qadhE/Pr_qadhE, Pf_qfumC/Pr_qfumC, Pf_qsucC/Pr_qsucC, Pf_qfabB/Pr_qfabB and Pf_qfabF/Pr_qfabF were used to amplify PAL, 4CL, STS, eno, adhE, fumC, sucC, fabB and fabF with cDNA as templates. Primers were first designed by Primer 3 software (http://bioinfo.ut.ee/primer3-0.4.0/). The specificity of primers were verified by running the resulting amplifying DNA products in agarose gels. RT-PCR assays were conducted by SYBR green PCR Master Mix (Takara, Dalian, China) on a LightCycler 480 II thermal cycler system (Roche, Mannheim, Germany) 34 . Five dilutions of the obtaining cDNAs were used to verify the efficiencies of RT-PCR and a negative control were conducting without cDNA added to confirm purity of the sample. 
Construction of different variant

